Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.36 USD | -7.61% | +0.76% | -35.92% |
28/06 | Sector Update: Health Care Stocks Edge Higher in Afternoon Trading | MT |
28/06 | Mizuho Securities Cuts Price Target on Apellis Pharmaceuticals to $49 From $52, Maintains Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.92% | 465.56Cr | |
+2.17% | 9.52TCr | |
-4.34% | 3.75TCr | |
+75.79% | 2.82TCr | |
-14.61% | 1.56TCr | |
-3.46% | 1.36TCr | |
-12.31% | 1.15TCr | |
+184.77% | 1.08TCr | |
-54.13% | 923.34Cr | |
+6.22% | 909.4Cr |
- Stock Market
- Equities
- APLS Stock
- News Apellis Pharmaceuticals, Inc.
- Apellis Pharmaceuticals to Seek Re-Examination of Negative CHMP Opinion on Pegcetacoplan for Geographic Atrophy